Literature DB >> 34907898

MicroRNA-155 contributes to host immunity against Toxoplasma gondii.

Yanan Xu1, Junhua Wu1, Xiaoqi Yuan1, Wenyuan Liu1, Jiewen Pan1, Binbin Xu1.   

Abstract

Toxoplasma gondii is well known to infect almost all avian and mammalian species including humans, with worldwide distribution. This protozoan parasite can cause serious toxoplasmosis, posing with a risk to public health. The role of microRNAs in the pathogenesis of T. gondii has not been well described. The aim of the present study was to investigate the role of microRNA-155 (miR-155) in mediating innate and adaptive immune responses during T. gondii infection in mice models. The survival and parasite burden in T. gondii-infected miR-155-/- and wild-type (WT) C57BL6 mice were compared. In these two mouse models, ELISA tests were used for analysis of Th1-associated, Th2-associated, and Th17-associated cytokines, and flow cytometry was used for analysis of the subpopulations of NK, NKT, CD8+T, CD4+T cells and regulatory T cells (Tregs), as well as Ly6Chi inflammatory monocytes and dendritic cells. The lack of miR-155 led to increased parasite burden and decreased survival of infected mice in contrast to WT mice. Innate and adaptive immune responses were reduced in the absence of miR-155, along with decreased proinflammatory mediators, Th-1-associated and Th-2-associated cytokines and accumulation of lymphocyte subpopulations. Also, CD8+ T cell exhaustion was also worsened in the absence of miR-155 via targeting of SHIP-1 and SOCS1, showing as up-regulated recruitment of Tregs and expression of PD-1, and down-regulated expression of IFN-γ and TNF-α in CD8+ T cells. Our results show that miR-155 is a critical immune regulator for the control of T. gondii infection, suggesting that miR-155 can be explored as a potential molecular target for boosting immunity against T. gondii. © Y. Xu et al., published by EDP Sciences, 2021.

Entities:  

Keywords:  Toxoplasma gondii; Toxoplasmosis; miR-155

Mesh:

Substances:

Year:  2021        PMID: 34907898      PMCID: PMC8672677          DOI: 10.1051/parasite/2021082

Source DB:  PubMed          Journal:  Parasite        ISSN: 1252-607X            Impact factor:   3.000


  36 in total

Review 1.  Advances in the Development of Anti-Toxoplasma gondii Vaccines: Challenges, Opportunities, and Perspectives.

Authors:  Jin-Lei Wang; Nian-Zhang Zhang; Ting-Ting Li; Jun-Jun He; Hany M Elsheikha; Xing-Quan Zhu
Journal:  Trends Parasitol       Date:  2019-02-01

2.  Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells.

Authors:  Elia D Tait; Kimberly A Jordan; Christopher D Dupont; Tajie H Harris; Beth Gregg; Emma H Wilson; Marion Pepper; Florence Dzierszinski; David S Roos; Christopher A Hunter
Journal:  J Immunol       Date:  2010-06-30       Impact factor: 5.422

Review 3.  Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis.

Authors:  Hany M Elsheikha; Christina M Marra; Xing-Quan Zhu
Journal:  Clin Microbiol Rev       Date:  2020-11-25       Impact factor: 26.132

4.  MicroRNA-155 Deficiency Exacerbates Trypanosoma cruzi Infection.

Authors:  Bijay K Jha; Sanjay Varikuti; Abhay R Satoskar; Bradford S McGwire; Gabriella R Seidler; Greta Volpedo
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

Review 5.  Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy.

Authors:  Sundee Dees; Rajkumar Ganesan; Sanjaya Singh; Iqbal S Grewal
Journal:  Eur J Immunol       Date:  2020-12-28       Impact factor: 5.532

Review 6.  Toxoplasma gondii: from animals to humans.

Authors:  A M Tenter; A R Heckeroth; L M Weiss
Journal:  Int J Parasitol       Date:  2000-11       Impact factor: 3.981

7.  Early precursor T cells establish and propagate T cell exhaustion in chronic infection.

Authors:  Daniel T Utzschneider; Sarah S Gabriel; David Chisanga; Renee Gloury; Patrick M Gubser; Ajithkumar Vasanthakumar; Wei Shi; Axel Kallies
Journal:  Nat Immunol       Date:  2020-08-24       Impact factor: 25.606

8.  MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer.

Authors:  Jan C Dudda; Bruno Salaun; Yun Ji; Douglas C Palmer; Gwennaelle C Monnot; Estelle Merck; Caroline Boudousquie; Daniel T Utzschneider; Thelma M Escobar; Rachel Perret; Stefan A Muljo; Michael Hebeisen; Nathalie Rufer; Dietmar Zehn; Alena Donda; Nicholas P Restifo; Werner Held; Luca Gattinoni; Pedro Romero
Journal:  Immunity       Date:  2013-04-18       Impact factor: 31.745

9.  MicroRNA: Biogenesis, Function and Role in Cancer.

Authors:  Leigh-Ann Macfarlane; Paul R Murphy
Journal:  Curr Genomics       Date:  2010-11       Impact factor: 2.236

10.  Adjuvantic cytokine IL-33 improves the protective immunity of cocktailed DNA vaccine of ROP5 and ROP18 against toxoplasma gondii infection in mice.

Authors:  Yu-Chao Zhu; Yong He; Jian-Fa Liu; Jia Chen
Journal:  Parasite       Date:  2020-04-21       Impact factor: 3.000

View more
  1 in total

1.  Integrative Analysis of RNA Expression and Regulatory Networks in Mice Liver Infected by Echinococcus multilocularis.

Authors:  Tingli Liu; Hong Li; Yanping Li; Liqun Wang; Guoliang Chen; Guiting Pu; Xiaola Guo; William C Cho; Majid Fasihi Harandi; Yadong Zheng; Xuenong Luo
Journal:  Front Cell Dev Biol       Date:  2022-03-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.